BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26541263)

  • 1. Serum dipeptidyl peptidase-4 is associated with multiple vertebral fractures in type 2 diabetes mellitus.
    Notsu M; Kanazawa I; Tanaka S; Yamaguchi T; Sugimoto T
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):332-7. PubMed ID: 26541263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum osteocalcin/bone-specific alkaline phosphatase ratio is a predictor for the presence of vertebral fractures in men with type 2 diabetes.
    Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T
    Calcif Tissue Int; 2009 Sep; 85(3):228-34. PubMed ID: 19641839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus.
    Kanazawa I; Yamaguchi T; Sugimoto T
    Osteoporos Int; 2011 Apr; 22(4):1191-8. PubMed ID: 20532480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Serum Uric Acid is a Risk Factor of Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes Mellitus.
    Tanaka KI; Kanazawa I; Notsu M; Sugimoto T
    Exp Clin Endocrinol Diabetes; 2020 Jan; 128(1):66-71. PubMed ID: 30562825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus.
    Tanaka KI; Kanazawa I; Kaji H; Sugimoto T
    Bone; 2017 Feb; 95():5-10. PubMed ID: 27836731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
    Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
    Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
    Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Bone Mineral Density, Bone Turnover Markers, and Vertebral Fractures with All-Cause Mortality in Type 2 Diabetes Mellitus.
    Miyake H; Kanazawa I; Sugimoto T
    Calcif Tissue Int; 2018 Jan; 102(1):1-13. PubMed ID: 28965188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes.
    Yamamoto M; Yamaguchi T; Yamauchi M; Yano S; Sugimoto T
    J Clin Endocrinol Metab; 2008 Mar; 93(3):1013-9. PubMed ID: 18160470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral fat obesity increases serum DPP-4 levels in men with type 2 diabetes mellitus.
    Tanaka S; Kanazawa I; Notsu M; Sugimoto T
    Diabetes Res Clin Pract; 2016 Jun; 116():1-6. PubMed ID: 27321309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.
    Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY
    Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients.
    Cao Y; Liu X; Xu H
    Clin Lab; 2012; 58(7-8):845-50. PubMed ID: 22997989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men.
    Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T
    Calcif Tissue Int; 2008 Nov; 83(5):324-31. PubMed ID: 18946627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance between Prevalent Vertebral Fracture and Vertebral Strength Estimated by the Finite Element Method Based on Quantitative Computed Tomography in Patients with Type 2 Diabetes Mellitus.
    Kiyohara N; Yamamoto M; Sugimoto T
    PLoS One; 2015; 10(12):e0144496. PubMed ID: 26642210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.
    Yamamoto M; Yamauchi M; Sugimoto T
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4030-7. PubMed ID: 23894157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum uric acid with bone mineral density and clinical fractures in Chinese type 2 diabetes mellitus patients: A cross-sectional study.
    Yan P; Zhang Z; Wan Q; Zhu J; Li H; Gao C; Ma H; Xu Y
    Clin Chim Acta; 2018 Nov; 486():76-85. PubMed ID: 30031772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the linagliptin, dipeptidyl peptidase-4 inhibitor, on bone fragility induced by type 2 diabetes mellitus in obese mice.
    Kanda J; Furukawa M; Izumo N; Shimakura T; Yamamoto N; Takahashi HE; Wakabayashi H
    Drug Discov Ther; 2020 Nov; 14(5):218-225. PubMed ID: 33116039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes.
    Yamamoto M; Yamaguchi T; Yamauchi M; Sugimoto T
    Diabetes Care; 2009 Dec; 32(12):2263-8. PubMed ID: 19752174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus.
    Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T
    Eur J Endocrinol; 2009 Feb; 160(2):265-73. PubMed ID: 18996964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening osteoporotic femoral neck without measuring bone mineral density with the use of tartrate resistant acid phosphatase-5b and serum-creatinine-to-cystatin C ratio in Japanese postmenopausal women.
    Yoshii I; Chijiwa T; Sawada N
    J Orthop Sci; 2020 Jul; 25(4):671-676. PubMed ID: 31337577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.